Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
21/04/2026 16:52
April 21 (Reuters) - Scope Fluidics SA SCPP.WA: UNIT BACTEROMIC STARTS COLLABORATION WITH US RESEARCH CENTER FOR FDA REGISTRATION TRIALS TRIALS TO TEST BACTEROMIC SYSTEM WITH EXPANDED UNI FAST PANEL COVERING UP TO 52 ANTIBIOTICS CLINICAL TRIAL RESULTS ARE REQUIRED FOR FDA SUBMISSION Source text: ID:nEM3q8jhCa Further company coverage: SCPP.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys